ID PA21_TROCA Reviewed; 151 AA. AC Q45Z30; DT 06-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 13-SEP-2005, sequence version 1. DT 16-JUN-2009, entry version 28. DE RecName: Full=Phospholipase A2, acidic 1; DE EC=3.1.1.4; DE AltName: Full=Phosphatidylcholine 2-acylhydrolase 1; DE Short=PLA-1; DE Flags: Precursor; OS Tropidechis carinatus (Australian rough-scaled snake). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Lepidosauria; Squamata; Scleroglossa; Serpentes; Colubroidea; OC Elapidae; Notechinae; Tropidechis. OX NCBI_TaxID=100989; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Venom gland; RX PubMed=16261251; DOI=10.1007/s00018-005-5384-9; RA St Pierre L., Woods R., Earl S.T.H., Masci P.P., Lavin M.F.; RT "Identification and analysis of venom gland-specific genes from the RT coastal taipan (Oxyuranus scutellatus) and related species."; RL Cell. Mol. Life Sci. 62:2679-2693(2005). CC -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2- CC acyl groups in 3-sn-phosphoglycerides. CC -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1- CC acylglycerophosphocholine + a carboxylate. CC -!- COFACTOR: Binds 1 calcium ion per subunit (By similarity). CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed by the venom gland. CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group I CC subfamily. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; DQ085836; AAZ22654.1; -; mRNA. DR HOVERGEN; Q45Z30; -. DR BRENDA; 3.1.1.4; 295067. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; IEA:UniProtKB-KW. DR GO; GO:0004623; F:phospholipase A2 activity; IEA:EC. DR GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW. DR GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW. DR GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro. DR InterPro; IPR016090; Phospholipase_A2. DR InterPro; IPR013090; Phospholipase_A2_AS. DR InterPro; IPR001211; Phospholipase_A2_euk. DR Gene3D; G3DSA:1.20.90.10; Phospholipase_A2; 1. DR PANTHER; PTHR11716; Phospholipase_A2; 1. DR Pfam; PF00068; Phospholip_A2_1; 1. DR PRINTS; PR00389; PHPHLIPASEA2. DR ProDom; PD000303; PhospholipaseA2; 1. DR SMART; SM00085; PA2c; 1. DR PROSITE; PS00119; PA2_ASP; 1. DR PROSITE; PS00118; PA2_HIS; 1. PE 2: Evidence at transcript level; KW Calcium; Disulfide bond; Hydrolase; Lipid degradation; Metal-binding; KW Secreted; Signal; Toxin. FT SIGNAL 1 27 Potential. FT CHAIN 28 151 Phospholipase A2, acidic 1. FT /FTId=PRO_0000043276. FT ACT_SITE 75 75 By similarity. FT ACT_SITE 126 126 By similarity. FT METAL 55 55 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 57 57 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 59 59 Calcium; via carbonyl oxygen (By FT similarity). FT METAL 76 76 Calcium (By similarity). FT DISULFID 38 104 By similarity. FT DISULFID 54 151 By similarity. FT DISULFID 56 72 By similarity. FT DISULFID 71 132 By similarity. FT DISULFID 78 125 By similarity. FT DISULFID 88 118 By similarity. FT DISULFID 111 123 By similarity. SQ SEQUENCE 151 AA; 16921 MW; 663C0EF2DEB9935A CRC64; MYPAHLLVLL AVCVSLLGAA SIPARPLNLY QFGNMIQCAN HGRRPTRHYM DYGCYCGKGG SGTPVDELDR CCQTHDDCYG EAEKLPACNY MMSGPYYNTY SYECNDGELT CKDNNDECKA FICNCDRTAA ICFARTPYND ANWNIDTKTR C //